Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05048784 · ClinicalTrials.gov registry record · Phase 1
A Study to Compare the Pharmacokinetics of Two Different Tablets of Sotorasib in Healthy Participants
A Phase 1 study, sponsored by Amgen.
- Completed
- Registry status
- Phase 1
- Development phase
- 145
- Enrollment target
NCT05048784 is a Phase 1 study that has completed, run by Amgen. The registered enrollment target is 145 participants.
The verdict
NCT05048784, a Phase 1 study, has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 145 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the pharmacokinetics (PK) of sotorasib dose A administered orally as 3 tablets (test) to sotorasib dose A administered orally as 8 tablets (reference).
Interventions
- DRUG Sotorasib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2022-02-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05048784
The ClinicalTrials.gov registry entry for NCT05048784 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sotorasib is the first listed.
NCT05048784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05048784 about?
NCT05048784 is a clinical study titled "A Study to Compare the Pharmacokinetics of Two Different Tablets of Sotorasib in Healthy Participants". The primary objective of this study is to compare the pharmacokinetics (PK) of sotorasib dose A administered orally as 3 tablets (test) to sotorasib dose A administered orally as 8 tablets (reference).
What is the current status of trial NCT05048784?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 145 participants. The study started on 2021-08-16. Estimated completion is 2022-02-18.
What interventions are being tested in trial NCT05048784?
The interventions under investigation include: Sotorasib (DRUG).
Who is sponsoring clinical trial NCT05048784?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.